AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

European Medical Solutions

Declaration of Voting Results & Voting Rights Announcements Feb 27, 2018

3942_dva_2018-02-27_77b4df5d-0b66-4b3e-a2d2-8a8364966de4.pdf

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

THIS%ANNOUNCEMENT%IS%NOT%FOR%RELEASE,%PUBLICATION%OR%DISTRIBUTION,%DIRECTLY%OR%INDIRECTLY,%IN%OR%INTO%THE% UNITED% STATES,% AUSTRALIA,% CANADA,% JAPAN% OR% ANY% JURISDICTION% WHERE% TO% DO% SO% WOULD% BE% UNLAWFUL.% OTHER% RESTRICTIONS%ARE%APPLICABLE.%PLEASE%SEE%THE%IMPORTANT%LEGAL%NOTICE%AT%THE%END%OF%THIS%ANNOUNCEMENT.

Regulated)information

Information)on)the)total)number)of)voting)rights)and)shares

Brussels,) Belgium,) 27 February 2018,) 7.00) am (CET) – ASIT) biotech (ASIT)H BE0974289218),% a% clinical% stage% biopharmaceutical% company% focused% on% the% research,% development% and% future% commercialization% of% breakthrough%immunotherapy%products%for%the%treatment%of%allergies,%discloses%the%information%required%under% article%15%of%the%law%of%2%May%2007%regarding%the%disclosure%of%important%shareholdings%in%listed%companies.

Denominator)– modified)on)23 February 2018 following)a)capital)increase:

  • New%shares%issued%following%the%capital%increase:%1,169,702
  • Total%number%of%shares%with%voting%rights:%16,432,246
  • Total%number%of%voting%rights%(=denominator):%16,432,246

Total%number%of%shares%with%voting%rights%upon%capital%increase:%16,432,246

***

About!ASIT!biotech!!

ASIT! biotech! is! a! Belgian! clinical! stage! biopharmaceutical! company! focused! on! the! development! and! future! commercialization! of! a! range! of! breakthrough! immunotherapy! products! for! the! treatment! of! allergies.! Thanks! to! its! innovative!ASIT+™!technology!platform,!ASIT!biotech!is!currently!the!only!developer!of!AIT!product!candidates!consisting!of!a! unique!mixture!of!highly!purified!natural!allergen!fragments!in!an!optimal! size! selection.!This!innovation! results!in!a! short treatment,!expected! to!improve! patient!compliance!and! realClife!effectiveness.!ASIT! biotech's! product! pipeline!entails! two! novel!ASIT+™!product!candidates!targeting!respiratory!allergy!with!the!highest!prevalence!(i.e.!grass!pollen:!gpCASIT+™!and! house!dust!mite:!hdmCASIT+™),! that!could!significantly!expand! the!current!immunotherapy!market.!The!Company!believes! that!its!innovative!ASIT+™!platform!is!flexible!and!would!be!applicable!across!a!range!of!allergies.

ASIT!biotech!has!a!headcount!of!22!staff!members,!at!its!headquarters!in!Brussels!and!a!laboratory!in!Liège,!Belgium.!

Further!information!can!be!found!at!www.asitbiotech.com.!!

Contacts!

Company! Thierry!Legon,!CEO ASIT!biotech Tel.:!+32!2!264!03!90 [email protected]

Media!and!Investor!Relations!C!France! NewCap

Dusan!Oresansky!/!Pierre!Laurent Tel.:!+33!1!44!71!94!92 [email protected]

Media!Relations!C!Belgium! LaureCEve!Monfort Tel.:!+32!2!290!90!93 [email protected]!! !

ForwardClooking!statements!

All statements!in! this!announcement! that!do!not! relate! to!historical!facts!and!events!are!"forwardClooking! statements".!In! some! cases,! these!forwardClooking! statements! can! be! identified! by! the! use! of!forwardClooking! terminology,! including! the! words!"believes,"!"estimates,"!"anticipates,"!"expects,"!"intends,"!"may,"!"will,"!"plans,"!"continue,"!"ongoing,"!"potential,"! "predict,"! "project,"! "target,"! "seek"! or! "should"! or,! in! each! case,! their! negative! or! other! variations! or! comparable! terminology! or! by! discussions! of! strategies,! plans,! objectives,! targets,! goals,! future! events! or! intentions.! ForwardClooking! statements!include!statements!regarding!the!Company's!intentions,!beliefs!or!current!expectations.!By!their!nature,!forwardC looking! statements! involve! known! and! unknown! risks! and! uncertainties! because! they! relate! to! events! and! depend! on! circumstances! that! may! or! may! not! occur! in! the! future.! ForwardClooking! statements! are! not! guarantees! of! future! performance.!Given!these!risks!and!uncertainties,!you!should!not!rely!on!forwardClooking!statements!as!a!prediction!of!actual! results.!Any!forwardClooking!statements!are!made!only!as!of! the!date!of! this!announcement!and,!without!prejudice! to! the! Company's!obligations!under!applicable!law!in relation!to!disclosure!and!ongoing!information,!the!Company!does!not!intend,! and!does!not!assume!any!obligation,!to!update!the!forwardClooking!statements!set!forth!in!this!announcement.!

Legal!notice!

This!announcement!does!not!constitute,!or!form!part!of,!an!offer!or!invitation!to!sell!or!issue,!or!any!solicitation!of!an!offer!to! purchase!or!subscribe!for!shares!of!ASIT!biotech!SA!(the!"Company"!and!the!"Shares").!Any!purchase!of,!subscription!for!or! application!for,!Shares!to!be!issued!in!connection!with!the!intended!offering!should!only!be!made!on!the!basis!of!information! contained!in! the! prospectus!and!any! supplements! thereto,!as! the!case!may! be.!This!announcement! does! not!constitute!a! prospectus! and! the! information! contained! herein! is! for! information! purposes! only! and! does! not! purport! to! be! full! or! complete.!Investors!should!not!subscribe!for!any!Shares!except!on!the!basis!of!the!information!contained!in!the!prospectus! that! the!Company!expects! to!publish!after!its!approval!by! the!Belgian!Financial!Services!and!Markets!Authority,!and!which! can!then!be!obtained!at!the!Company's!registered!office!and!on!www.asitbiotech.com

This!announcement!is!not!for!distribution,!directly!or!indirectly,!in!or!into!the!United!States!or!to!any!U.S.!person!within!the! meaning! of! the!U.S.! Securities! Act! of! 1933,! as! amended!(the! "Securities! Act").! The! Shares! have! not! been! and!will! not! be! registered!under! the!Securities!Act!and!may!not!be!offered!or!sold!in! the!United!States,!except!pursuant! to!an!exemption! from!the!registration!requirements!of!the!Securities!Act.!The!Company!has!not!registered,!and!does!not!intend!to!register,! any!portion!of!the!intended!offering!of!Shares!in!the!United!States,!and!does!not!intend!to!conduct!a!public!offering!of!Shares! in!the!United!States.

This!announcement!and!the!information!contained!herein!are!not!for!publication,!distribution!or!release!in!or!into!the!United States,!Australia,!Canada,!Japan!or!any!jurisdiction!where!to!do!so!would!constitute!a!violation!of!the!relevant!laws!of!such! jurisdiction.!

The!Company!is!responsible!for!the!information!contained!in!this!press!release.

Talk to a Data Expert

Have a question? We'll get back to you promptly.